Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase 2 ...

When he found 130 handwritten pages of witness statements relating to a triple murder on the island of Benbecula in the 19th ...

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 - WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Zenas BioP ...

- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of ...

We've tested dozens of tablets over the years, but these are the ones our readers actually purchased most in 2025.

AI has advanced to a place where we can no longer rely on people having weird numbers of fingers or unhinging their jaws in horrifying ways to distinguish a real video from a fake one. For every ...

Patience is important when battling weeds. Different species of these pesky plants can grow in almost any season. Once you eliminate one type of weed, it may feel like another type almost immediately ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

Border czar Tom Homan said on Thursday that his family has been in hiding because of death threats and reporters trying to seek their location. Law enforcement officers and Immigration and Customs ...

Pennsylvania State Police are looking for a suspect with a distinct characteristic. On Saturday, PSP Kiski Station posted on social media that they’re investigating a crime involving a person with ...

The abundance, distribution, and origin of lunar surface water has recently drawn significant scientific interest, owing to ...

Zenas BioPharma shares jumped in premarket trading after the company reported highly positive trial data for its multiple-sclerosis treatment. Shares traded over 59% higher ahead of the morning bell ...